generalized anxiety disorder - Nursing Case Study

Pathophysiology

• Primary mechanism: Dysregulation of neurotransmitters, particularly serotonin, norepinephrine, and gamma-aminobutyric acid (GABA), leads to heightened brain activity and persistent anxiety.

• Secondary mechanism: Overactivity in the amygdala and prefrontal cortex disrupts the brain's ability to regulate emotional responses, contributing to excessive worry and fear.

• Key complication: Chronic activation of the stress response can result in increased risk for cardiovascular issues and impaired daily functioning.

Patient Profile

Demographics:

28-year-old female, high school teacher

History:

• Key past medical history: Diagnosed with generalized anxiety disorder 2 years ago; history of tension headaches

• Current medications: Sertraline 50 mg daily, occasional ibuprofen for headaches

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased anxiety and difficulty concentrating

• Key symptoms: Persistent worry, fatigue, restlessness, occasional heart palpitations

• Vital signs: Blood pressure 145/90 mmHg, heart rate 105 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F

Section 1

New Complications:

During a follow-up appointment, the patient reports experiencing increased frequency and intensity of her headaches, now occurring almost daily and often accompanied by nausea and photophobia. She also mentions feeling more fatigued despite trying to maintain a regular sleep schedule. Upon physical examination, the patient's vital signs reveal a persistent elevation in blood pressure at 150/95 mmHg and a heart rate of 110 bpm, suggesting that her anxiety may be contributing to uncontrolled hypertension. There is a notable increase in muscle tension in her neck and shoulders, likely exacerbating her tension headaches.

Lab work is ordered to rule out other potential causes of her symptoms. Results show slightly elevated cortisol levels, indicating chronic stress. Thyroid function tests return normal, ruling out hyperthyroidism as a contributing factor. Given these findings, the healthcare team considers the possibility that her current dose of sertraline may no longer be sufficient in managing her generalized anxiety disorder symptoms. The patient is counseled on lifestyle modifications, including regular exercise and relaxation techniques, to help manage her anxiety and stress levels.

These developments highlight the need for a comprehensive approach to treatment, addressing both pharmacological and non-pharmacological interventions. The team discusses the potential for adjusting her sertraline dosage or exploring alternative medications, alongside cognitive-behavioral therapy to improve coping strategies. As the patient navigates these new complications, continued monitoring of her cardiovascular status and mental health is essential to prevent further deterioration and to enhance her overall quality of life.

Section 2

Response to Interventions:

Following the adjustments to the patient's treatment plan, including an increase in the sertraline dosage from 50 mg to 75 mg daily, and the introduction of cognitive-behavioral therapy sessions twice a month, the healthcare team closely monitors her progress over the next six weeks. The patient reports a modest improvement in her anxiety symptoms, noting a slight decrease in the intensity of her headaches and a reduction in the frequency of nausea episodes. However, the fatigue persists, and she continues to struggle with maintaining energy levels throughout the day.

The patient's cardiovascular parameters show partial improvement. Her blood pressure has decreased slightly, now averaging around 140/90 mmHg, and her heart rate has stabilized at 100 bpm. While these changes suggest a positive response to the intervention, they indicate that her hypertension remains suboptimally controlled, necessitating ongoing attention. The patient has also started practicing guided imagery and progressive muscle relaxation, which she finds beneficial in managing her stress and muscle tension.

Clinically, the healthcare team identifies a need for continued adjustment and monitoring. They consider the introduction of a low-dose beta-blocker to further address her hypertension and provide additional relief for her anxiety-related symptoms. The potential side effects and interactions with her current medications are evaluated carefully. This multi-faceted approach aims to further stabilize her condition, decrease the risk of new complications, and improve her overall quality of life. As the patient progresses, the team remains vigilant, ready to adjust the treatment plan as needed based on ongoing assessments and patient feedback.

Section 3

New Complications:

As the healthcare team continues to monitor the patient's progress, they notice the emergence of new complications. Over the past two weeks, the patient reports experiencing increasing episodes of dizziness and lightheadedness, particularly upon standing. This orthostatic hypotension is concerning, as it suggests a possible side effect of the newly introduced beta-blocker, which was aimed at better controlling her hypertension and alleviating anxiety symptoms. Upon evaluation, her blood pressure readings indicate significant fluctuations, with measurements dropping to 110/70 mmHg when moving from a sitting to a standing position. Her heart rate, while initially stabilized, now shows variations between 80 and 95 bpm.

Additionally, the patient has been experiencing sporadic episodes of insomnia, which she attributes to heightened anxiety about her persistent fatigue and the recent dizzy spells. These sleep disturbances further exacerbate her daytime tiredness, creating a challenging cycle of fatigue and anxiety. The healthcare team considers these developments as moderate complications, requiring a re-evaluation of her medication regimen and non-pharmacological interventions. The possibility of adjusting the beta-blocker dosage or exploring alternative antihypertensive options is discussed, alongside reinforcing strategies for managing anxiety-induced insomnia.

In response to these new complications, the team decides to temporarily reduce the beta-blocker dosage while increasing the frequency of cognitive-behavioral therapy sessions to once a week, aiming to provide more robust support for her anxiety and sleep issues. They also initiate a comprehensive review of her lifestyle, including dietary habits and physical activity, to identify areas that might contribute to her symptoms. This holistic approach is intended to address the intertwined nature of her physical and psychological health, preventing further complications and optimizing her quality of life.

Section 4

Response to Interventions:

Following the adjustment of the beta-blocker dosage and the intensification of cognitive-behavioral therapy (CBT) sessions, the healthcare team observes some promising developments in the patient's condition. Over the next couple of weeks, there is a noticeable improvement in her dizziness and lightheadedness episodes, with her orthostatic blood pressure readings now showing less dramatic fluctuations. Her sitting blood pressure stabilizes at approximately 125/80 mmHg, and upon standing, it decreases to 115/75 mmHg, indicating a more controlled response. Her heart rate also stabilizes, consistently ranging between 82 and 88 bpm. These changes suggest a positive response to the modifications in her medication regimen.

Additionally, the patient reports a mild reduction in her anxiety levels and a slight improvement in her sleep quality, attributing these changes to the increased frequency of CBT sessions. She is able to fall asleep more easily and experiences fewer interruptions during the night, which in turn has a beneficial effect on her daytime energy levels. The team notes her subjective reports of feeling more rested and less anxious, which are crucial in breaking the cycle of fatigue and anxiety. However, she still experiences occasional bouts of insomnia linked to stressors in her personal life, indicating the need for ongoing psychological support.

Despite these advancements, the team remains vigilant, recognizing the importance of continuous monitoring and adjustment. They encourage the patient to maintain her engagement in CBT and explore relaxation techniques to further improve her sleep hygiene. Moreover, they emphasize the need for regular follow-ups to assess her blood pressure, heart rate, and overall well-being, ensuring that any potential complications are promptly addressed. This proactive and multifaceted approach aims to solidify the progress made and pave the way for further improvements in her health and quality of life.

Section 5

As the healthcare team continues to monitor the patient, they observe a change in her status that requires further evaluation. Over the next few weeks, the patient begins to experience a resurgence of anxiety symptoms, particularly in the late afternoons and evenings. She reports experiencing a tight sensation in her chest and an overwhelming sense of worry that is difficult to control, despite ongoing CBT sessions and medication adherence. This escalation in symptoms prompts the team to conduct a comprehensive reassessment to identify any underlying factors contributing to this change.

During the reassessment, the patient's vital signs remain stable, with her blood pressure at 120/78 mmHg and heart rate ranging from 80 to 85 bpm. However, the team notes a subtle increase in her reported stress levels, correlating with recent personal challenges, including increased responsibilities at work and familial obligations. To gain further insight, the healthcare team orders additional diagnostic tests, including thyroid function tests and a complete metabolic panel, suspecting that underlying physiological changes may be exacerbating her anxiety. The results reveal a slightly elevated TSH level, suggesting subclinical hypothyroidism, which could be contributing to her increased anxiety and fatigue.

In light of these findings, the team collaborates to adjust the treatment plan. They initiate a low-dose levothyroxine regimen to address the thyroid dysfunction and recommend an integrative approach that combines medication management with enhanced coping strategies. The patient is encouraged to continue with CBT while incorporating mindfulness-based stress reduction techniques to manage her anxiety more effectively. The team also plans for more frequent follow-up appointments to closely monitor her thyroid function, anxiety levels, and overall well-being, aiming to achieve a balanced and comprehensive approach to her care.